This is a prescription medicine. A prescription is required from your veterinarian before we can supply this product. Please ensure that you have read the "How to Order" page before ordering this item.
We apologise that we are unable to display a photograph of the packaging or provide you with more information regarding this prescription medicine. Australian legislation prohibits the advertisement of prescription drugs to consumers.
All of our products are APVMA or TGA approved and identical to those used by your veterinarian. Please call or email us if you have any queries about any of the products on our site.
|Drug Name and Strength||Hydrocortisone aceponate 0.584 mg/mL|
|Indication||Symptomatic relief of inflammatory and pruritic skin conditions when used under the direction of a veterinarian. Aids in the reduction of dermatological signs in localised lesions associated with flea allergy dermatitis.|
|Contraindications||Administration onto cutaneous ulcers.|
|Actions||Hydrocortisone aceponate (HCA) is a double ester of hydrocortisone with unique properties. Cortavance is a modern, potent, and well tolerated topical glucocorticoid especially suited for the treatment of allergic skin conditions in dogs. Cortavance can be used on small or large lesions (up to one-third of the body surface area). Cortavance controls inflammatory and immunological reactions in skin, leading to regression of signs (erythema, oedema, cell infiltration) and associated sensations (itching, pain). Due to its unique metabolism in the epidermis, Cortavance has no systemic or local side effects when used at label dose, and negligible systemic bioavailabilty (0.2%).|
|Precautions||In case of concurrent lesions of bacterial, fungal or parasitic origin, the infectious condition should be controlled by an adequate treatment. In the absence of specific information, use in animals suffering from Cushing syndrome and diabetes should be based on a risk-benefit assessment. For conditions requiring more than seven days' consecutive use or periodic preventative treatment, the responsible veterinarian should subject the use of the product to a risk-benefit assessment.Care should be taken to avoid spraying into the eyes of the animal.The safety of Cortavance Spray in breeding, pregnant or lactating dogs has not been established, therefore its use is not recommended in these dogs. Use in young animals (under 7 months of age) should be based on risk-benefit assessment and subject to regular clinical evaluations.Will irritate the eyes. Avoid contact with eyes, wash product out immediately with water if contact is made with eyes. Spray in a well ventilated area. Flammable; do not spray on a naked flame and do not smoke while handling this product. Wash hands after use, if any skin contact is made. May cause allergies. May cause birth defects.First Aid If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131 126.Disposal Dispose of empty container by wrapping with paper and putting in garbage.|
|Storage||Store below 30°C (room temperature). Store away from direct sunlight.|
|MSDS (external link)||Cortavance Spray MSDS|
|Label (external link)||Cortavance Spray Label|
|Manufacturer||Virbac (Australia) Pty Limited|